Clinical Trial Update: Assessing Imaging as a Tool in Monitoring and Predicting the Progression of Parkinson Disease [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating imaging to monitor and predict progression in Parkinson disease. Completed study.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Snippet

Sponsor: Institute for Neurodegenerative Disorders | Conditions: Parkinson Disease | Phase 2 | Status: COMPLETED